Amit Mahipal, M.B.B.S.

  1. Oncologist

Location

  1. Rochester, Minnesota

Languages

English

Amit Mahipal, MBBS, MPH, specializes in the treatment of gastrointestinal cancers. In particular, he specializes in the treatment of:

  • bile duct cancer
  • pancreatic cancer
  • liver cancer
  • colorectal cancer

Dr. Mahipal is also involved in the development of novel therapeutic agents for gastrointestinal cancers. He is a member of Phase 1 clinical trial program at Mayo clinic and involved in drug development for oncology patients. He is the principal investigator for several early phase clinical trials including first-in-human studies. He has spearheaded several investigator initiated trials for pancreatic, liver and bile duct cancers. He is involved in developing different markers that could potentially be utilized in developing personalized therapies in the field of oncology.

In addition to his clinical and research activities, Dr. Mahipal is active in education, providing mentorship to residents and fellows. He authors expert content and publishes in high-impact scientific journals.

  • Gastrointestinal cancers
  • Cholangiocarcinoma
  • Hepatocellular carcinoma
  • Pancreatic cancer
  • Colon cancer
  • Gastroesophageal cancer
  • Early cancer therapeutics/Phase 1 clinical trials
  1. 2011
    Chief FellowThomas Jefferson University
  2. 2011
    Fellow - Hematology/OncologyThomas Jefferson University Hospital
  3. 2008
    Residency - Categorical Internal MedicineUniversity of Connecticut Health Center
  4. 2005
    MPH - EpidemiologyUniversity of Minnesota
  5. 2003
    MBBSMaulana Azad Medical College, Delhi University

Certifications

  1. 2011
    HematologyAmerican Board of Internal Medicine
  2. 2011
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2007
    Program Director’s Letter of Commendation for Excellence in Patient CareUniversity of Connecticut Health Center
  2. 2006
    Program Director’s Letter of Commendation for Excellence in Patient CareUniversity of Connecticut Health Center
  3. 2005
    Henry Blackburn AwardUniversity of Minnesota
  4. 2005
    Program Director’s Letter of Commendation for Excellence in Patient CareUniversity of Connecticut Health Center
  5. 2003
    James L. Craig FellowshipUniversity of Minnesota

Professional memberships

  1. 2022 - present
    Co-ChairClinical Trials Operations Team
  2. 2022 - 2023
    MemberABIM item-Writing Task Force
  3. 2021 - present
    Scientific ReviewerASCO Conquer Cancer's Grant selection Committee
  4. 2021 - present
    LeadHPB Clinical Trial Committee
  5. 2021 - present
    Distinguished FellowApollo Hospitals Educational and Research Foundation (AHERF)
  6. 2021 - present
    Executive Committee MemberHepatopancreaticobiliary Disease Group
  7. 2021
    MemberASCO Question Writing Group
  8. 2020 - present
    MemberCholangiocarcinoma foundation Fellowship Review Committee
  9. 2020 - present
    Executive committee memberInternational Cholangiocarcinoma Research Network - Executive Committee
  10. 2018 - present
    Physician LeadWatson Clinical Trial Matching Committee
  11. 2018 - 2021
    Co-ChairMayo Clinic Pancreas Tumor Board
  12. 2018 - 2021
    Co-ChairPractice/Access Group, Hepatobiliary Disease Group; Practice/Access Group
  13. 2018 - present
    ChairPancreatic SPORE, Mayo Clinic Cancer Center
  14. 2014 - 2016
    MemberH. Lee Moffitt Cancer Center, Department of Tumor Biology
  15. 2014 - 2016
    MemberH. Lee Moffitt Cancer Center, International Relations Steering Committee
  16. 2014 - 2016
    MemberH. Lee Moffitt Cancer Center, Clinical Research Action Committee
  17. 2014 - 2016
    MemberH. Lee Moffitt Cancer Center, Research and Academic Career Committee
  18. 2014 - 2016
    Program Committee MemberFlorida American Society of Clinical Oncology
  19. 2014 - 2016
    MemberFlorida American Society of Clinical Oncology
  20. 2013 - 2016
    MemberH. Lee Moffitt Cancer Center, Chemical Biology and Molecular Medicine Committee
  21. 2011 - 2016
    MemberH. Lee Moffitt Cancer Center, Scientific Review Committee
  22. 2011 - 2016
    MemberH. Lee Moffitt Cancer Center, Personalized Clinical Trial Committee
  23. 2010 - present
    MemberAmerican Association for Cancer Research
  24. 2008 - 2011
    MemberAmerican Society of Hematology
  25. 2008 - present
    MemberAmerican Society of Clinical Oncology
  26. 2005 - 2008
    MemberAmerican Medical Association
  27. 2005 - present
    MemberDelta Omega (Public Health Honor Society)

Publications